Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-18-328133
Filing Date
2018-11-15
Accepted
2018-11-15 17:18:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 d655865d425.htm 425 24253
2 GRAPHIC g655865g1116032759890.jpg GRAPHIC 4725
3 GRAPHIC g655865g1116032800046.jpg GRAPHIC 3678
  Complete submission text file 0001193125-18-328133.txt   37634
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Subject) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-30929 | Film No.: 181188051
SIC: 2834 Pharmaceutical Preparations

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filed by) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations